Healthcare -
Biotechnology - NASDAQ - IL
$ 3.91
0.256 %
$ 273 M
Market Cap
-9.09
P/E
Price Target
Average
79.03%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
-0.00%
Net Income
Estimate
35.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alpha Tau Medical Ltd.
Wall Street analysts predict an average 1-year price target for DRTS of $7 , with forecasts ranging from
a
low of
$7 to a high of $7 .
DRTS Lowest Price Target
Wall Street Target
7 USD
79.03%
DRTS Average Price Target
Wall Street Target
7 USD
79.03%
DRTS Highest Price Target
Wall Street Target
7 USD
79.03%
REVENUE FORECAST
Revenue Forecast Chart DRTS
EBIT FORECAST
EBIT Forecast Chart DRTS
NET INCOME FORECAST
Net Income Chart DRTS